Harvard Bioscience enters debt waiver and amendment; substantial doubt about going concern

HARVARD BIOSCIENCE INC

Fifth Amendment waives default on net leverage ratio covenant as of Dec 31, 2024; covenant testing suspended through March 31, 2025 if milestones met.
Revolving credit commitment capped at outstanding amount; interest rate increased to SOFR + 400 bps; monthly amortization payments required.
Company must achieve refinancing milestones (e.g., term sheet by May 23, 2025) and close refinancing by June 30, 2025.
Unless refinanced by June 30, 2025, Company states it will be unable to pay debt and fund operations; substantial doubt about going concern.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.